Saturday 17 October 2026 Export AMRX’s income statement to Excel — free account

AMNEAL PHARMACEUTICALS, INC.

AMRX Healthcare Drug Manufacturers Specialty & Generic

AMNEAL PHARMACEUTICALS, INC.’s revenue for fiscal 2025 (year ended December 2025) was $3.0 billion, up 8.05% from fiscal 2024. In the quarter to June 2026, revenue grew 9.89%, EPS grew 157.1%, free cash flow fell 351.4% and total debt rose 8.22%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

19.18 0.07 −0.36%

Follow AMRX

Alert me

Market cap: $6.2B
P/E: 38.4×
Fwd P/E: 51.6×
Dividend yield: —
F-score: 7/9
Altman Z: 1.94
Beneish M: −2.68
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(5.80%)	(79.69%)	(137.24%)	(395.84%)
Piotroski F-Score Full definition →		7	7	7	7
ROA Full definition →		0.17%	2.01%	3.54%	4.37%
ROIC Full definition →		10.04%	11.25%	11.44%	11.05%
Return on Tangible Assets Full definition →		0.42%	4.89%	8.06%	10.35%
Average Days of Receivables Full definition →		110.25	108.29	102.02	119.51
Free Cash Flow per Share Full definition →		0.76	0.73	0.60	(0.04)
Free Cash Flow Full definition →		237.88	227.73	189.67	(11.59)
Capital Expenditures Full definition →		(89.87)	(112.26)	(116.17)	(212.37)
Other line items
Cash ROIC Full definition →		8.81%	8.10%	6.82%	(0.41%)
Accounts Receivable Turnover Full definition →		3.57	3.61	3.79	3.41
Accounts Payable Turnover Full definition →		2.65	2.55	2.89	2.73
Inventory Turnover Full definition →		3.07	3.13	3.01	2.94
Average Days of Payables Full definition →		143.92	145.83	129.52	139.15
Days of Inventory on Hand Full definition →		120.85	116.14	125.35	130.81
Tax Rate Full definition →		(0.16)	(0.08)	0.00	0.07
Research and Development Expense of Revenue Full definition →		7.01%	6.17%	6.06%	5.63%
Selling, General and Administrative Expense of Revenue Full definition →		17.34%	17.45%	17.97%	18.34%
Share Based Compensation of Revenue Full definition →		1.05%	1.06%	1.10%	1.14%
Interest Coverage Full definition →		1.45	1.63	1.83	2.00
Operating CF/Net income Full definition →		55.55	4.72	2.50	1.28
Depreciation/Fixed assets Full definition →		0.61	0.56	0.51	0.46
Capex/Depreciation Full definition →		(0.34)	(0.46)	(0.51)	(1.01)
Revenue per Share Full definition →		9.34	9.63	9.64	9.77
Operating CF per Share Full definition →		1.04	1.09	0.97	0.63
Capex per Share Full definition →		(0.29)	(0.36)	(0.37)	(0.67)
Capex to Sales Full definition →		0.03	0.04	0.04	0.07

Show all line items

Columns are period end dates

Stockrow Weekly